Cite
HARVARD Citation
Sukumar, S. et al. (n.d.). Characterization of MK-4166, a clinical agonistic mAb that targets human GITR and inhibits the generation and activity of Tregs. European journal of cancer. pp. S104-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sukumar, S. et al. (n.d.). Characterization of MK-4166, a clinical agonistic mAb that targets human GITR and inhibits the generation and activity of Tregs. European journal of cancer. pp. S104-. [Online].